1. Home
  2. NURO vs RDHL Comparison

NURO vs RDHL Comparison

Compare NURO & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NURO
  • RDHL
  • Stock Information
  • Founded
  • NURO 1996
  • RDHL 2009
  • Country
  • NURO United States
  • RDHL Israel
  • Employees
  • NURO N/A
  • RDHL N/A
  • Industry
  • NURO Medical/Dental Instruments
  • RDHL Biotechnology: Pharmaceutical Preparations
  • Sector
  • NURO Health Care
  • RDHL Health Care
  • Exchange
  • NURO Nasdaq
  • RDHL Nasdaq
  • Market Cap
  • NURO 8.2M
  • RDHL 6.8M
  • IPO Year
  • NURO N/A
  • RDHL N/A
  • Fundamental
  • Price
  • NURO $4.38
  • RDHL $5.23
  • Analyst Decision
  • NURO
  • RDHL
  • Analyst Count
  • NURO 0
  • RDHL 0
  • Target Price
  • NURO N/A
  • RDHL N/A
  • AVG Volume (30 Days)
  • NURO 19.9K
  • RDHL 10.4K
  • Earning Date
  • NURO 02-24-2025
  • RDHL 04-07-2025
  • Dividend Yield
  • NURO N/A
  • RDHL N/A
  • EPS Growth
  • NURO N/A
  • RDHL N/A
  • EPS
  • NURO N/A
  • RDHL N/A
  • Revenue
  • NURO $3,767,764.00
  • RDHL $3,707,000.00
  • Revenue This Year
  • NURO N/A
  • RDHL $224.90
  • Revenue Next Year
  • NURO N/A
  • RDHL $82.69
  • P/E Ratio
  • NURO N/A
  • RDHL N/A
  • Revenue Growth
  • NURO N/A
  • RDHL N/A
  • 52 Week Low
  • NURO $2.66
  • RDHL $5.20
  • 52 Week High
  • NURO $4.73
  • RDHL $20.28
  • Technical
  • Relative Strength Index (RSI)
  • NURO 67.35
  • RDHL 31.92
  • Support Level
  • NURO $4.16
  • RDHL $5.52
  • Resistance Level
  • NURO $4.39
  • RDHL $5.71
  • Average True Range (ATR)
  • NURO 0.06
  • RDHL 0.27
  • MACD
  • NURO 0.00
  • RDHL -0.04
  • Stochastic Oscillator
  • NURO 91.56
  • RDHL 2.38

About NURO NeuroMetrix Inc.

NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

Share on Social Networks: